Patients with COPD with raised eosinophil levels can benefit from biologic treatment with dupilumab, producing consistent ...

Lung disease may develop without obvious changes in appearance. Learn the respiratory symptoms and risk factors that should ...

To whom does the recommendation apply? This recommendation applies to adults who do not recognize or report respiratory symptoms. It does not apply to persons with symptoms such as chronic cough, ...

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2026 introduces the concept of “disease stability” (DS), classifies patients with ≥1 moderate exacerbation in the previous year as ...

Obstructive lung diseases like COPD cause trouble when you're exhaling air. Restrictive lung diseases like pulmonary fibrosis make it harder to inhale air, reducing total lung capacity. Two types of ...

November is National Chronic Obstructive Pulmonary Disease Awareness Month. It's time to raise awareness about lung disease within our communities. By understanding the causes, reducing our risk ...

L-arginine plus liposomal vitamin C added to pulmonary rehabilitation is associated with reduced fatigue than placebo among patients with advanced COPD and chronic respiratory failure.

Chronic obstructive pulmonary disease, or COPD, is an ongoing group of lung conditions that include chronic bronchitis and emphysema. COPD is the result of damaged lung tissue, which leads to ...

Inhaler device errors are common and may impact the effectiveness of the delivered drug. There is a paucity of up-to-date systematic reviews (SRs) or meta-analyses (MAs) of device errors in asthma and ...

A clinical trial for patients with chronic obstructive pulmonary disease (COPD) shows that laughter therapy can reduce breathing difficulties and is as effective as more traditional breathing ...

A. Screen her for COPD due to her smoking history. B. Counsel her about smoking cessation and offer pharmacotherapy to help her quit smoking. C. Do not screen her for COPD because she has not smoked ...

A vaccine designed to protect against rhinoviruses, which cause the great majority of common colds and exacerbate chronic respiratory illnesses, has shown encouraging early results in a phase 1 ...